脳腫瘍の診断と治療の世界市場分析:タイプ別(MRI、CTスキャン、組織サンプリング、PET-CTスキャン、脳動脈瘤、腰椎穿刺、分子検査、脳波)、地域別、セグメント予測、2014 – 2025...市場調査レポートについてご紹介

【英文タイトル】Brain Tumor Diagnosis And Therapeutics Market Analysis By Type (MRI, CT Scan, Tissue Sampling, PET-CT Scan, Cerebral Arteriogram, Lumbar Puncture, Molecular Testing, And EEG), By Region, And Segment Forecasts, 2014-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
Chapter 3. Brain Tumor Diagnosis and Therapeutics Market Variables, Trends & Scope
3.1. Market Segmentation & Scope
3.2. Market Driver Analysis
3.3. Penetration & Growth Prospect Mapping
3.4. SWOT Analysis, by Factor
3.4.1. Political
3.4.2. Economic
3.4.3. Technological
3.5. Industry Analysis – Porter’s
Chapter 4. Brain Tumor Diagnosis and Therapeutics Market: Type Estimates & Trend Analysis
4.1. Type Movement Analysis & Market Share, 2015 & 2025
4.2. Market Size Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following type:
4.2.1. MRI
4.2.2. CT scan
4.2.3. Tissue sampling
4.2.4. PET-CT scan
4.2.5. Cerebral arteriogram
4.2.6. Lumbar puncture
4.2.7. Molecular testing
4.2.8. EEG
Chapter 5. Brain Tumor Diagnosis and Therapeutics Market: Therapeutics Estimates & Trend Analysis
5.1. Therapeutics Movement Analysis & Market Share, 2015 & 2025
5.2. Market Size Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following therapeutics:
5.2.1. Surgery
5.2.2. Radiation therapy
5.2.3. Chemotherapy
5.2.4. Immunotherapy
5.2.5. Targeted therapy
Chapter 6. Brain Tumor Diagnosis and Therapeutics Market: Regional Estimates & Trend Analysis
6.1. Brain Tumor Diagnosis and Therapeutics Regional Market Share, 2015 & 2025
6.2. North America
6.2.1. U.S.
6.2.1.1. U.S. revenue estimates and forecasts, by type, 2014 – 2025 (USD Million)
6.2.1.2. U.S. Revenue estimates and forecasts, by therapeutics, 2014 – 2025 (USD Million)
6.2.2. Canada
6.2.2.1. Canada revenue estimates and forecasts, by type, 2014 – 2025 (USD Million)
6.2.2.2. Canada revenue estimates and forecasts, by therapeutics, 2014 – 2025 (USD Million)
6.3. Europe
6.3.1. UK
6.3.1.1. UK revenue estimates and forecasts, by type, 2014 – 2025 (USD Million)
6.3.1.2. UK revenue estimates and forecasts, by therapeutics, 2014 – 2025 (USD Million)
6.3.2. Germany
6.3.2.1. Germany revenue estimates and forecasts, by type, 2014 – 2025 (USD Million)
6.3.2.2. Germany revenue estimates and forecasts, by therapeutics, 2014 – 2025 (USD Million)
6.4. Asia Pacific
6.4.1. Japan
6.4.1.1. Japan revenue estimates and forecasts, by type, 2014 – 2025 (USD Million)
6.4.1.2. Japan revenue estimates and forecasts, by therapeutics, 2014 – 2025 (USD Million)
6.4.2. India
6.4.2.1. India revenue estimates and forecasts, by type, 2014 – 2025 (USD Million)
6.4.2.2. India revenue estimates and forecasts, by therapeutics, 2014 – 2025 (USD Million)
6.5. Latin America
6.5.1. Brazil
6.5.1.1. Brazil revenue estimates and forecasts, by type, 2014 – 2025 (USD Million)
6.5.1.2. Brazil revenue estimates and forecasts, by therapeutics, 2014 – 2025 (USD Million)
6.5.2. Mexico
6.5.2.1. Mexico revenue estimates and forecasts, by type, 2014 – 2025 (USD Million)
6.5.2.2. Mexico revenue estimates and forecasts, by therapeutics, 2014 – 2025 (USD Million)
6.6. MEA
6.6.1. South Africa
6.6.1.1. South Africa revenue estimates and forecasts, by type, 2014 – 2025 (USD Million)
6.6.1.2. South Africa revenue estimates and forecasts, by therapeutics, 2014 – 2025 (USD Million)
Chapter 7. Competitive Landscape
7.1. Strategy Framework
7.2. Company Profiles
7.2.1. GE Healthcare
7.2.1.1. Company overview
7.2.1.2. Geographic foothold
7.2.1.3. Financial performance
7.2.1.4. Product benchmarking
7.2.1.5. Strategic initiatives
7.2.2. Hitachi, Ltd.
7.2.2.1. Company overview
7.2.2.2. Geographic foothold
7.2.2.3. Financial performance
7.2.2.4. Product benchmarking
7.2.2.5. Strategic initiatives
7.2.3. Philips Healthcare
7.2.3.1. Company overview
7.2.3.2. Geographic foothold
7.2.3.3. Financial performance
7.2.3.4. Product benchmarking
7.2.3.5. Strategic initiatives
7.2.4. Siemens Healthineers
7.2.4.1. Company overview
7.2.4.2. Geographic foothold
7.2.4.3. Financial performance
7.2.4.4. Product benchmarking
7.2.4.5. Strategic initiatives
7.2.5. Toshiba Corporation
7.2.5.1. Company overview
7.2.5.2. Geographic foothold
7.2.5.3. Financial performance
7.2.5.4. Product benchmarking
7.2.5.5. Strategic initiatives
7.2.6. Fujifilm Corporation
7.2.6.1. Company overview
7.2.6.2. Geographic foothold
7.2.6.3. Financial performance
7.2.6.4. Product benchmarking
7.2.6.5. Strategic initiatives
7.2.7. Shimadzu Corporation
7.2.7.1. Company overview
7.2.7.2. Geographic foothold
7.2.7.3. Financial performance
7.2.7.4. Product benchmarking
7.2.7.5. Strategic initiatives
7.2.8. Carestream Health
7.2.8.1. Company overview
7.2.8.2. Geographic foothold
7.2.8.3. Financial performance
7.2.8.4. Product benchmarking
7.2.8.5. Strategic initiatives


【レポート販売概要】

■ タイトル:脳腫瘍の診断と治療の世界市場分析:タイプ別(MRI、CTスキャン、組織サンプリング、PET-CTスキャン、脳動脈瘤、腰椎穿刺、分子検査、脳波)、地域別、セグメント予測、2014 – 2025
■ 英文:Brain Tumor Diagnosis And Therapeutics Market Analysis By Type (MRI, CT Scan, Tissue Sampling, PET-CT Scan, Cerebral Arteriogram, Lumbar Puncture, Molecular Testing, And EEG), By Region, And Segment Forecasts, 2014-2025
■ 発行日:2017年1月4日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707143
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。